英国立博ladbrokes

　　2023年3月20日至23日，第95届DCAT Week在美国纽约如期举行。作为全球制药和生物医药供应链中规模最大、备受瞩目的行业盛事之一，数百家成员公司与全球客户齐聚在此，在为期4天的DCAT WEEK期间，举行了多轮高级别的现场洽谈和交流会。

　　NEW YORK, NY - On March 20ththrough March 23rd, 2023, Midtown New York City was home to the 95thAnnual DCAT Week, one of the world’s largest and highly recognized and attended business events for the pharmaceutical industry. During the 4-day event, hundreds of member companies engage in high-level meetings with customers, typically engaging at the senior management or C-suite level. The event serves as one of the premier events in the United States for the global pharmaceutical and biopharmaceutical manufacturing value chain.

　　作为本次运动的主要赞助商之一，英国立博ladbrokes全方位展示我们为客户提供全球化端到端CDMO效劳的能力。此次运动进一步展现了英国立博ladbrokes作为全球领先CDMO效劳平台的定位，我们将以“技术立异”和“效劳立异”为指导，为制药企业、生物科技公司、科研机构等提供全类别、端到端的CDMO效劳，加速药物上市进程，让好药更早惠及公共。

　　Porton USA served as one of the premier sponsors for the event this year, sponsoring a number of activities and resources throughout the course of 4 days. Strategically, this aligns well with aiming to bring Porton’s highly technical and client oriented CDMO service offering to customers in the United States. The company’s involvement in this highly visible event was crucial to ensuring that customers in the US can look to Porton to help solve technical challenges and bring innovative drugs to market.

　　3月20日(星期一)，英国立博ladbrokes股份董事长兼CEO居年丰先生受邀出席DCAT Annual Membership Forum，全面介绍了英国立博ladbrokes的全球化结构，如斯洛文尼亚新研爆发产基地和即将投用的美国制剂研发园地等。别的，居年丰先生向加入本届会员论坛的全球资深人士分享了英国立博ladbrokes对前沿技术、数字化能力建设等等的思考，他体现，我们希望通过新技术的引进和落地，提高研发和生产效率，并逐步构建起卓越的“技术立异”和“效劳立异”的开放协作CDMO平台。

　　On Monday, March 20th, Porton Chairman & CEO, Oliver Ju, delivered a presentation at the DCAT Annual Membership Forum, an invite-only presentation platform to highlight exciting company news within the DCAT Member Company network. Mr. Ju presented on Porton’s exciting global expansion plan, highlighting Porton’s new site in Slovenia as well as the new drug product facility in the United States. Additionally, the presentation also showcased Porton’s focus on next generation technologies and digitalization to optimize process efficiency and control during R&D and manufacturing.

　　3月21日(星期二)英国立博ladbrokes股份作为赞助商之一，还积极加入了DCAT会员招待会。该运动吸引了1100多名注册者加入(实到700多人)。英国立博ladbrokes治理层、BD团队和市场团队加入了此次运动，并借此时机向各方与会代表介绍了英国立博ladbrokes。

　　On Tuesday, March 21st,Porton was one of the headline sponsors of the DCAT Member Reception. The event had over 1100 registrants and over 700 attendees, and company representatives got the chance to give DCAT members an overview of Porton’s capabilities and highlights. The event was attended by all Porton leadership, as well as the business development and marketing teams.

　　3月22日(周三)英国立博ladbrokes加入了Disruption Busters 系列在线研讨会。该系列研讨会上，来自世界各地的专家们围绕行业热点、生长趋势、特定领域最佳实践和应用等多个主题进行了精彩演讲。英国立博ladbrokes股份赞助了一场关于供应链危害的讨论会，建议需要找到合适的相助同伴，以确保研发管线和商业化生产的乐成。

　　On Wednesday, Porton was one of the sponsors of the Disruption Busters Seminar series. The seminar series highlights key topics and areas that are fast moving and impactful within the industry, and key experts from around the world deliver high value presentations on best practices and key initiatives. Porton’s sponsorship covered a discussion on supply chain risk and mitigation, and stressed the need to find the right partner to ensure pipeline and commercialization success. Porton’s sponsorship also covered a tabletop display where interested attendees connected with Porton’s business development team.

　　3月23日，作为DCAT最引人注目的年度压轴运动之一，DCAT年度晚宴在纽约希尔顿Midtown酒店如期举行。英国立博ladbrokes治理层、BD、市场和HR团队热情加入了现场运动。今年晚宴有1500多名嘉宾盛装出席，以著名喜剧演员Jerry Seinfeld的演出结束精彩的一天。

　　On March 23rd, DCAT’s grand finale was held at the New York Hilton Midtown, where the DCAT Annual Dinner was held. With an attendance of over 1500 attendees and guests, this is one of DCAT’s highest profile events. The night served as a fantastic celebration of 4 days of hard work and great success for the company. The night was capped off with a performance by well known comedian and actor, Jerry Seinfeld.

　　在本届DCAT Week上，英国立博ladbrokes同全球相助同伴进行了广泛交流，配合探讨和推动行业生长，并告竣了多项相助意向。借助本次大会，公司充分展示我们在小分子原料药、制剂、基因细胞治疗等业务领域的全球化结构，有力转达我们致力于成为全球最开放、最立异、最可靠的制药效劳平台，让好药更早惠及公共的使命。